These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21817166)

  • 1. Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics.
    Gerszten RE; Asnani A; Carr SA
    Circ Res; 2011 Aug; 109(4):463-74. PubMed ID: 21817166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualification and Verification of Protein Biomarker Candidates.
    Zhao Y; Brasier AR
    Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restructuring proteomics through verification.
    Boja E; Rivers R; Kinsinger C; Mesri M; Hiltke T; Rahbar A; Rodriguez H
    Biomark Med; 2010 Dec; 4(6):799-803. PubMed ID: 21133699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic approach in the search of new cardiovascular biomarkers.
    Gallego-Delgado J; Lazaro A; Osende JI; Barderas MG; Blanco-Colio LM; Duran MC; Martin-Ventura JL; Vivanco F; Egido J
    Kidney Int Suppl; 2005 Dec; (99):S103-7. PubMed ID: 16336560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics Research in Cardiovascular Medicine and Biomarker Discovery.
    Lam MP; Ping P; Murphy E
    J Am Coll Cardiol; 2016 Dec; 68(25):2819-2830. PubMed ID: 28007144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate-based proteomics in the search for biomarkers of cardiovascular disease.
    Anderson L
    J Physiol; 2005 Feb; 563(Pt 1):23-60. PubMed ID: 15611012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selected reaction monitoring/multiple reaction monitoring-based mass spectrometry approach for the accurate quantitation of proteins: clinical applications in the cardiovascular diseases.
    Gianazza E; Tremoli E; Banfi C
    Expert Rev Proteomics; 2014 Dec; 11(6):771-88. PubMed ID: 25400095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward an integrated pipeline for protein biomarker development.
    Drabovich AP; Martínez-Morillo E; Diamandis EP
    Biochim Biophys Acta; 2015 Jun; 1854(6):677-86. PubMed ID: 25218201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular proteomics: implications for clinical applications.
    Schoenhoff FS; Fu Q; Van Eyk JE
    Clin Lab Med; 2009 Mar; 29(1):87-99. PubMed ID: 19389553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted and Untargeted Proteomics Approaches in Biomarker Development.
    Sobsey CA; Ibrahim S; Richard VR; Gaspar V; Mitsa G; Lacasse V; Zahedi RP; Batist G; Borchers CH
    Proteomics; 2020 May; 20(9):e1900029. PubMed ID: 31729135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of proteomics in clinical cardiovascular biomarker discovery.
    Edwards AV; White MY; Cordwell SJ
    Mol Cell Proteomics; 2008 Oct; 7(10):1824-37. PubMed ID: 18667414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular diagnostic biomarkers: the past, present and future.
    Suzuki T
    Circ J; 2009 May; 73(5):806-9. PubMed ID: 19325191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
    Pham TV; Piersma SR; Oudgenoeg G; Jimenez CR
    Expert Rev Mol Diagn; 2012 May; 12(4):343-59. PubMed ID: 22616700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.
    Thomas A; Lenglet S; Chaurand P; Deglon J; Mangin P; Mach F; Steffens S; Wolfender JL; Staub C
    Thromb Haemost; 2011 Jul; 106(1):20-33. PubMed ID: 21614412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted proteomics for validation of biomarkers in clinical samples.
    Ye X; Blonder J; Veenstra TD
    Brief Funct Genomic Proteomic; 2009 Mar; 8(2):126-35. PubMed ID: 19109305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted proteomics: a bridge between discovery and validation.
    Harlan R; Zhang H
    Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics and metabolomics for mechanistic insights and biomarker discovery in cardiovascular disease.
    Barallobre-Barreiro J; Chung YL; Mayr M
    Rev Esp Cardiol (Engl Ed); 2013 Aug; 66(8):657-61. PubMed ID: 24776335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry.
    Chou CY; Chang CT; Chen CJ
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8580. PubMed ID: 31502717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.